The prevalence of hepatitis B core antibody positivity in donors for liver transplantation in Saudi Arabia

Saudi Medical Journal

Volumn 23, Issue 3, 2002, Pages 298-300

  Al Sebayel, Mohammed I ^a   Khalaf, Hatem A ^a   Ramirez, Carlo G ^b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b National Kidney Transplant Institute   (Philippines)

Author keywords

Donor; Hepatitis B virus; Hepatitis B virus core antibody; Liver transplantation; Prevalence

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DONOR; FAR EAST; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INDIAN; INFECTION RISK; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RECIPIENT; SAUDI ARABIA; SEROLOGY; VIRUS TRANSMISSION;

ADULT; FEMALE; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HUMANS; LIVER TRANSPLANTATION; MALE; PREVALENCE; RETROSPECTIVE STUDIES; SAUDI ARABIA; SEROEPIDEMIOLOGIC STUDIES; TISSUE DONORS;

EID: 0036217682     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Infectivity of hepatic allografts with antibodies to hepatitis B virus
2. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population
3. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors
4. Hepatitis B virus in Saudi Arabia
5. Transmission of hepatitis B by transplantation of livers from positive for antibody to hepatitis B core antigen
6. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease
7. De novo infection of hepatitis B virus in patients with orthotopic liver transplantation: Analysis by determining complete sequence of the genome
8. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants
9. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia
10. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen
11. Can hepatitis B core antibody positive livers be used safely for transplantation: Hepatitis B virus detection in the liver of individuals who are hepatitis B core antibody positive
12. The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient
13. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors